All emerging evidence about COVID-19 impact and practical implications of implementing the tool will continue to be reviewed by the Risk Assessment Sub Group.
Bydd yr holl dystiolaeth sy'n dod i'r amlwg am effaith COVID-19 a goblygiadau ymarferol rhoi'r adnodd ar waith yn parhau i gael eu hadolygu gan yr Is-grŵp Asesu Risg.